SFA
ELDN icon

Sequoia Financial Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

Sequoia Financial Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,250
Closed -$23K – 367
2019
Q2 		$23K Hold
1,250
– – ﹤0.01% 369
2019
Q1 		$90K Hold
1,250
– – 0.01% 358
2018
Q4 		$36K Buy
1,250
+278
+29% +$17.7K ﹤0.01% 289
2018
Q3 		$82K Buy
+972
New +$99.2K 0.01% 312

Other funds holding ELDN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sequoia Financial Advisors's ELDN Position: Q3 2019 in Review

Sequoia Financial Advisors sold out of Eledon Pharmaceuticals (ELDN) in Q3 2019, closing a stake of 1,250 shares — an estimated $23K sold.

Sequoia Financial Advisors first reported a position in ELDN in Q3 2018 and held it in 4 quarters. The position peaked at $90K in Q1 2019. 15 funds tracked by Wall St. Rank hold ELDN as of Q3 2019.

  • Sequoia Financial Advisors reported no remaining Eledon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Sequoia Financial Advisors sold 1,250 Eledon Pharmaceuticals shares in Q3 2019, an estimated $23K.
  • Sequoia Financial Advisors first reported a position in Eledon Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Sequoia Financial Advisors's Eledon Pharmaceuticals position peaked at $90K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2019.

Based on Sequoia Financial Advisors's 13F filing for Q3 2019, filed 22 Oct 2019.